MedTrace Logo

A Healthy Volunteer Study With Inhaled GSK573719 and Placebo

NCT00803673 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-07-21

No results posted yet for this study

Summary

This study is to look at a new formulation of GSK573719 to see if it is safe and tolerated in healthy volunteers

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

100mcg

100mcg '719

DRUG

500mcg

500mcg '719

DRUG

1000mcg

1000mcg '719

DRUG

Placebo

Placebo '719

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-05
Primary Completion
2008-10-16
Completion
2008-10-16

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00803673 on ClinicalTrials.gov